Video

Cancer Survivors Should Discuss COVID-19 Risks with Their Health Care Providers

Expert Dr. Sara Hurvitz discusses why cancer survivors should discuss their risk factors during the COVID-19 pandemic with their healthcare providers.

The new coronavirus, also called COVID-19, is particularly concerning for patients with cancer. However, survivors, while not as immunocompromised as those in active treatment, should still discuss their risk factors with their physicians to determine what, if any, extra precautions they should take.

At the 2020 Miami Breast Cancer Conference® and Educated Patient Breast Cancer Summit, CURE® spoke with Dr. Sara Hurvitz, an associate professor of medicine at the University of California, Los Angeles, about what questions survivors should ask their medical teams to stay safe during the pandemic.

Transcription:

I don’t think that most patients who are survivors who have already been treated for their breast cancer and are not currently on chemotherapy or other therapies that lower the white (blood cell) count, they’re not necessarily at a higher risk of developing it than other patients.

But it’s important to talk to one’s oncologist and primary care physician to gauge, based on my age, based on other medical conditions that I have, or based on the medications that I’m taking, how do you gauge what my risk is, and what activities should I avoid, or what activities am I OK to do?

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.